Baseline Characteristics of 987 Individuals With Stable Coronary Heart Disease by Amino Terminal Fragment of the Prohormone Brain-Type
Natriuretic Peptide (NT-proBNP) Quartile*
Kirsten Bibbins-Domingo, et al. JAMA 2007;297:169-176
Baseline Measures of Other Known Prognostic Markers by Amino Terminal Fragment of the Prohormone Brain-Type Natriuretic
Peptide (NT-proBNP) Quartile Among 987 Individuals With Stable Coronary Heart Disease*
Kirsten Bibbins-Domingo, et al. JAMA 2007;297:169-176
Survival Free of Cardiovascular Events or Death by NT-proBNP Quartile
Kirsten Bibbins-Domingo, et al. JAMA 2007;297:169-176
Adverse Cardiovascular Outcomes by Quartile of Amino Terminal Fragment of the
Prohormone Brain-Type Natriuretic Peptide (NT-proBNP)*
Kirsten Bibbins-Domingo, et al. JAMA 2007;297:169-176
Association of NT-proBNP With Any Cardiovascular Event or Death After
Adjusting for Available Prognostic Markers
Kirsten Bibbins-Domingo, et al. JAMA 2007;297:169-176
Association of Log Amino Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) per 1 SD Increase With Specific Cardiovascular Outcomes After
Adjusting for Other Prognostic Markers
Kirsten Bibbins-Domingo, et al. JAMA 2007;297:169-176
Association of Various Cut Points of Amino Terminal Fragment of the Prohormone Brain-Type
Natriuretic Peptide (NT-proBNP) Cardiovascular Events or
Death
Kirsten Bibbins-Domingo, et al. JAMA 2007;297:169-176
